Lehigh Valley Health Network is opening what it is describing as COVID-free hospitals for elective surgeries. The health network described the term COVID-free as a hospital that has been quarantined throughout the pandemic – a stand-alone building that has never seen a COVID-19 case and is physically separated from those that care for patients with COVID-19.

Lehigh Valley Physician Group is re-opening more than 50 LVPG practices across the Valley that were closed in early April due to the coronavirus outbreak and social distancing measures.

The owner of the family-operated Chaar, a Lehigh Valley-based chain of pet supply stores, said his company was thriving in the opening months of 2020. Then, the COVID-19 crisis hit. Chaar disagrees with the state's handling of the crisis and says that "the way things were done created a disaster for our economy."

It was in the early 2000s that the Right to Repair issue started taking hold, said Emma Horst-Martz, campaign associate with PennPIRG, the Pennsylvania branch of the U.S. PIRG, a consumer advocacy organization.

Long before the coronavirus paralyzed the country, healthcare was a top concern among most Pennsylvanians. And healthcare will remain a top issue through the crisis and well after the November national elections, according to experts who have been monitoring long-term trends.

A blood test that can detect cancer early has shown what the Geisinger health network officials are calling “promising results.”

Patient First is providing drive-up appointment-only COVID-19 testing at its location along Paper Mill Road in Wyomissing in Berks County.

Local health networks are embracing telehealth in the age of the coronavirus, and see it as a sea change in the industry moving forward.

One mental health professional opens up about how the industry and their clients are adjusting to life amid the pandemic.

INOVIO, the Doylestown-based pharmaceutical company, has completed the first phase of its clinical trial for a COVID-19 vaccine. All 40 healthy volunteers in the trial have now received their first dose, INOVIO says.